Neo Health joins GBMA under new membership tier

Thursday, September 28, 2023

Canberra, ACT

A leading Australian healthcare company, Neo Health, has joined the Generic and Biosimilar Medicines Association (GBMA) as its first ‘Affiliate Member’, marking the ongoing growth of the peak body for affordable medicines.

Reflecting the diversity of the Australian healthcare eco-system, GBMA created the entry-level membership tier for medicine and technology manufacturers, suppliers, industry associations and patient groups, with aligned values and views.

GBMA’s Independent Chair, Professor Jane Halton AO PSM, said the Board and members all welcomed Neo Health at an important time in the medicine policy landscape1 with cost-of-living pressures and the increasing rate of chronic disease among Australians2.

Neo Health is an Australian based company specialising in over the counter (OTC), prescription, wellness, and personal care solutions. Their aim is to provide products for all therapeutic categories, across multiple channels and global markets to help people live healthier, happier lives.

With connections across the affordable medicines sector, an Affiliate membership of the GBMA was a ‘positive and strategic’ fit, according to Neo Health Managing Director, Mr Aman Madan.

“We share GBMA’s core objectives to ensure all Australians have secure supply and timely access to high-quality, safe and affordable medicines” Mr Madan said.

GBMA’s Chief Executive Officer, Ms Marnie Peterson, said the GBMA is working closely with Government, members, and stakeholders, to develop and implement effective policy reforms that better protect patients against the cost-of-living increases.

“The GBMA looks forward to working with Neo Health and all members to ensure Australian patients can continue to access affordable, high-quality medicines, and support those most in need.”

-ENDS-

Media inquiries:
Jannette Cotterell
Executive Counsel Australia
0419 204 059
jcotterell@executivecounsel.com.au

ABOUT GBMA

The Generic and Biosimilar Medicines Association (GBMA) is the peak representative body of generic and biosimilar medicine suppliers in Australia. Its members ensure that all Australians are offered the highest quality generic and biosimilar medicines in the world whilst providing affordable community health outcomes that benefit all Australians.

For more information, please contact the GBMA – admin@gbma.com.au or visit www.gbma.com.au

ABOUT NEO HEALTH

Neo Health is a proudly Australian-owned company with experience in innovation and leadership spanning more than 25 years, servicing pharmaceutical companies, pharmacy chains and grocery retailers.

Neo Health develops and licenses over the counter, prescription, and complementary medicines, medical devices, niche, and innovative products for the Australian market – Neo Health | OTC products for today and tomorrow

1 https://www.pbs.gov.au/info/news/2022/12/refreshed-national-medicines-policy
2 Treasury.gov.au/policy-topics/measuring-what-matters/dashboard/prevalence-chronic-conditions.

 

More Articles

Thank you for visiting our website

The information a reader is about to be referred to may not comply with the Australian regulatory requirements.

Further information relevant to the Australian environment is available from the Australian Government, Department of Health.

Please click “Continue” to leave this website and proceed to the selected site.